Studying how a mother's glucose control during pregnancy affects her baby's glucose levels after birth
Glucose Control and Metabolic Adaptation in Offspring of Women With Gestational Diabetes Recruited to the DiGest Study
Cambridge University Hospitals NHS Foundation Trust · NCT04192422
This study looks at how well a mother's blood sugar is controlled during pregnancy to see if it affects her baby's blood sugar levels after birth.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Sex | All |
| Sponsor | Cambridge University Hospitals NHS Foundation Trust (other) |
| Locations | 1 site (Cambridge, Cambridge) |
| Trial ID | NCT04192422 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the relationship between maternal glucose control during pregnancy and the subsequent glucose regulation in newborns. By enrolling mothers and their babies who participated in the DiGest Trial, the study will collect data on glucose levels without any interventions. The goal is to understand how maternal health impacts neonatal outcomes, particularly in the context of gestational diabetes and hypoglycemia.
Who should consider this trial
Good fit: Ideal candidates for this study are mothers who have participated in the DiGest Trial and their newborns.
Not a fit: Patients who have not been enrolled in the DiGest Trial will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights that improve management strategies for mothers with gestational diabetes and enhance the health of their newborns.
How similar studies have performed: While this study builds on existing knowledge, it focuses on a specific population and may provide new insights into maternal and neonatal health.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * mothers and their babies who have been enrolled in DiGest Trial and who have provided informed consent Exclusion Criteria: * none
Where this trial is running
Cambridge, Cambridge
- Addenbrookes Hospital — Cambridge, Cambridge, United Kingdom (RECRUITING)
Study contacts
- Study coordinator: kathryn beardsall
- Email: kb274@cam.ac.uk
- Phone: 07565964631
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: GDM, Hypoglycemia